Position in JNJ
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,611,213
+$1,576,976 QoQ
Shares Held
22,094
+33.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#1,539
of 4,676 holders
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $20,079,575 across 8 Drug Manufacturers - General names. JNJ ranks #2 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,238 | $8,681,475 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
22,094 | $5,611,213 | |
| 3 | ABBV |
AbbVie Inc.
|
9,774 | $2,459,529 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,797 | $1,130,414 | |
| 5 | PFE |
Pfizer Inc
|
42,927 | $1,033,682 | |
| 6 | AMGN |
Amgen Inc
|
1,326 | $480,171 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,527 | $376,085 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,430 | $307,006 |
All Filings in JNJ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,611,213 | 22,094 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,034,237 | 16,504 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,687,245 | 12,985 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,129,919 | 11,487 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,276,531 | 8,357 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,398,197 | 8,431 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $1,043,577 | 7,216 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,090,825 | 6,731 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $839,396 | 5,743 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $850,429 | 5,376 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,161,756 | 7,412 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $829,991 | 5,329 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,185,454 | 7,162 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $930,465 | 6,003 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,050,360 | 5,946 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $916,612 | 5,611 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,014,469 | 5,715 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,068,696 | 6,030 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $948,412 | 5,544 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $864,025 | 5,350 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $799,483 | 4,853 | Shares | Sole | 2021-08-13 | |
| 2020-09-30 | $1,414,360 | 9,500 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||